MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) is a biotechnology company, that for several years has been conducting drug and alcohol research and has created health prediction technologies using AI and machine learning.  The Company has expertise in using speech analytics as a prediction tool for drug and alcohol intoxication and has created a world first voice and AI powered prediction model for drug and alcohol intoxication for use in consumer and enterprise situations.  The Company is developing a comprehensive enterprise platform using voice and powered by AI for use in detecting drug and alcohol intoxication in workplaces, law enforcement, mental health and telehealth.